How CA 125 is used in routine clinical practice

By Petignat P.   Joris F.   Obrist R.  

European Journal of Cancer, Vol. 36, Iss. 15, 2000-10 ,pp. : 1933-1937

Elsevier

Access to resources Recommend Favorite

Clinical Value of CA125, CA19-9, CEA, CA72-4, and TPA in Borderline Ovarian Tumor

By Tamakoshi K.   Kikkawa F.   Shibata K.   Tomoda K.   Obata N.H.   Wakahara F.   Tokuhashi Y.   Ishikawa H.   Kawai M.   Tomoda Y.  

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 67-72

Academic Press

Access to resources Recommend Favorite

Potential Clinical Utility of CA-125 in Responsive but Persistent Large-Volume Ovarian Cancer Following Platinum-Based Chemotherapy:

By Markman M.   Kennedy A.   Kim J.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 593-595

Elsevier

Access to resources Recommend Favorite

Improvement of Clinical Staging in Cervical Cancer with Serum Squamous Cell Carcinoma Antigen and CA 125 Determinations

By Massuger L.F.A.G.   Koper N.P.   Thomas C.M.G.   Dom K.E.L.   Schijf C.P.T.  

Gynecologic Oncology, Vol. 64, Iss. 3, 1997-03 ,pp. : 473-476

Elsevier

Access to resources Recommend Favorite

Measurement of CA-125 in Trophoblastic Disease

By Kohorn E.I.  

Gynecologic Oncology, Vol. 78, Iss. 1, 2000-07 ,pp. : 39-42

Elsevier

Access to resources Recommend Favorite